Cargando…

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention

BACKGROUND: Patients undergoing percutaneous coronary intervention (PCI) often develop atrial fibrillation (AF). We investigated the clinical effects of AF status on in-hospital mortality and complications in patients with PCI using a recent large-scale nationwide dataset. METHODS: Using a claims-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamaguchi, Toka, Iwanaga, Yoshitaka, Nakai, Michikazu, Morita, Yusuke, Inoko, Moriaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640652/ https://www.ncbi.nlm.nih.gov/pubmed/34901804 http://dx.doi.org/10.1016/j.cjco.2021.06.018

Ejemplares similares

Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention
por: Morita, Yusuke, et al.
Publicado: (2019)

Reduction in Planned Percutaneous Coronary Interventions After the Policy Change for Ischemia Assessment in Japan
por: Kanaoka, Koshiro, et al.
Publicado: (2023)

Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling
por: Seko, Yuta, et al.
Publicado: (2018)

Association between induction of the self-management system for preventing readmission and disease severity and length of readmission in patients with heart failure
por: Nakane, Eisaku, et al.
Publicado: (2021)

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention
por: Mirra, M, et al.
Publicado: (2014)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
por: Yu, Yunan, et al.
Publicado: (2022)

Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention
por: Takeda, Teruki, et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
por: Lianos, Ioannis, et al.
Publicado: (2022)

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
por: Kozieł, Monika, et al.
Publicado: (2020)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Sambola, Antonia, et al.
Publicado: (2016)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center
por: Rusia, Akash, et al.
Publicado: (2019)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
por: Poirier, Caylie M., et al.
Publicado: (2023)

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
por: Bogacki, Paweł, et al.
Publicado: (2016)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
por: Baldus, Stephan, et al.
Publicado: (2023)

Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
por: Puurunen, Marja, et al.
Publicado: (2014)

Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
por: De Vecchis, Renato, et al.
Publicado: (2016)

Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy
por: Okune, Mana, et al.
Publicado: (2021)

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
por: De Luca, Leonardo, et al.
Publicado: (2021)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
por: Beaulieu, Marie-Claude, et al.
Publicado: (2021)

Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
por: Kim, Sung Soo, et al.
Publicado: (2021)

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
por: Abdulrahman, Balen, et al.
Publicado: (2023)

Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion
por: Mikhaylov, Evgeny N, et al.
Publicado: (2017)

(123)I‐BMIPP single‐photon emission computed tomography for diagnosing chest pain in patients with nonobstructive coronary angiograms: Takotsubo or vasospasm?
por: Seko, Yuta, et al.
Publicado: (2017)

Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention
por: Suzuki, Sho, et al.
Publicado: (2019)

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
por: Berteotti, M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_225s174goqnuucpo5cjj8d4dsp